Literature DB >> 15766466

[Veracity of smokers' reports of abstinence at smoking cessation clinics].

M Barrueco1, C Jiménez Ruiz, L Palomo, M Torrecilla, P Romero, J A Riesco.   

Abstract

OBJECTIVE: To assess the reliability of smokers' response as criteria for measuring abstinence and the necessity or not of confirming abstinence with carbon monoxide (CO) measurement. PATIENTS AND METHODS: A multicenter, prospective, longitudinal study was carried out on patients over 18 years of age from 5 smoking cessation clinics who underwent treatment with nicotine or bupropion. When the patient attended the clinic at 15, 30, 60, 90, and 180 days, abstinence was checked by self-reporting and expired-air CO levels. Sensitivity, specificity, and positive, negative, and overall predictive value of patient reporting, measured CO levels, and the 2 procedures in combination were calculated.
RESULTS: A total of 904 smokers (476 men and 428 women) with a mean (SD) age of 42.51 (10.09) years were enrolled in the study. Of the 904 patients that made up the study population, 820, 776, 687, 719, and 679, respectively, attended the scheduled visits to check abstinence. Self-reported point-prevalence abstinence at 15 days was 74.5% and at 180 days was 57.6% while abstinence determined by expired-air CO was 75.7% and 59.4% respectively. Results according to self-reporting, CO measurement, and the 2 methods in combination were not significantly different (P<.05) at any of the points in time. Neither sensitivity nor specificity showed significant differences in relation to patient variables.
CONCLUSION: The reliability of self-reported abstinence from smoking is high. Measurement of CO is therefore not essential, although it could be advisable for motivating patients rather than as a way of confirming abstinence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766466     DOI: 10.1016/s1579-2129(06)60414-x

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  7 in total

1.  Effectiveness of intensive group and individual interventions for smoking cessation in primary health care settings: a randomized trial.

Authors:  Maria Ramos; Joana Ripoll; Teresa Estrades; Isabel Socias; Antonia Fe; Rosa Duro; Maria José González; Margarita Servera
Journal:  BMC Public Health       Date:  2010-02-23       Impact factor: 3.295

2.  Usage and effectiveness of a fully automated, open-access, Spanish Web-based smoking cessation program: randomized controlled trial.

Authors:  Guillermo Mañanes; Miguel A Vallejo
Journal:  J Med Internet Res       Date:  2014-04-23       Impact factor: 5.428

3.  Metric properties of the "prescribe healthy life" screening questionnaire to detect healthy behaviors: a cross-sectional pilot study.

Authors:  Paola Bully; Alvaro Sanchez; Gonzalo Grandes; Haizea Pombo; Ma Soledad Arietalenizbeaskoa; Veronica Arce; Catalina Martinez
Journal:  BMC Public Health       Date:  2016-12-07       Impact factor: 3.295

4.  Machine Learning Data Imputation and Classification in a Multicohort Hypertension Clinical Study.

Authors:  William Seffens; Chad Evans; Herman Taylor
Journal:  Bioinform Biol Insights       Date:  2016-05-09

5.  E-Cigarettes for Immediate Smoking Substitution in Women Diagnosed with Cervical Dysplasia and Associated Disorders.

Authors:  Shirley A James; Ellen M Meier; Theodore L Wagener; Katherine M Smith; Barbara R Neas; Laura A Beebe
Journal:  Int J Environ Res Public Health       Date:  2016-03-04       Impact factor: 3.390

6.  Comparison and prevalence of smoking among Saudi females from different Departments of the College of Applied Medical Sciences in Dammam.

Authors:  Khalid Ansari; Faraz Ahmed Farooqi
Journal:  Int J Health Sci (Qassim)       Date:  2017 Nov-Dec

7.  [Do COPD patients lie about their smoking habit?]

Authors:  Virginia Almadana Pacheco; Cristina Benito Bernáldez; Estefanía Luque Crespo; Rafael Perera Louvier; Julio César Rodríguez Fernández; Agustín S Valido Morales
Journal:  Aten Primaria       Date:  2020-07-30       Impact factor: 1.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.